CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia

Amann, Laura C., Gandal, Michael J., Lin, Robert, Liang, Yuling, Siegel, Steven J. · 2010 · Pharmaceutical Research

Abstract

Purpose Nonadherence to antipsychotic medications is a major obstacle preventing optimal outcomes for patients with schizophrenia. Extended release systems exist in the form of depot injections, but these formulations exhibit several disadvantages. To address these concerns, we previously demonstrated proof of concept for an antipsychotic implant containing risperidone and the biodegradable polymer poly(lactic-co-glycolic) acid (PLGA). Methods We build upon recently published data by utilizing a scalable single-screw extrusion system for the production of PLGA-risperidone implants. Implants were composed of 40% risperidone and 60% PLGA, with varying ratios of lactide to glycolide (50:50, 65:35, 75:25 or 85:15). Risperidone release was assessed in vitro and in vivo in rats, and Level A, B and C correlations (IVIVCs) attempted for all. Bioavailability was verified with locomotor testing Results Level B analysis yielded the greatest correlation between in vitro and in vivo data (R (2) = 0.9425), while Level C yielded the lowest (R (2) = 0.8336). Although, based on qualitative results, a Level A correlation was not achieved, it did produce an R (2) of 0.9261. Locomotor testing demonstrated that peak serum concentrations coincide with significant reductions in activity. Conclusion Data demonstrate the applicability of our modeling system and advance long-term, implantable antipsychotics toward clinical application.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11095-010-0152-4

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 41 references

Cited by

See all 104

Metadata

Authors
Amann, L. C., Gandal, M. J., Lin, R., Liang, Y., & Siegel, S. J.
Affiliations
University of Pennsylvania (US)
Corresponding author
Siegel, Steven J.
Venue
Pharmaceutical Research
Published
2010-04-27
Volume
27
Issue
8
Pages
1730-1737
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W2036441297
Cited by
99
References
41
Citations by year
2026: 1 · 2025: 11 · 2024: 6 · 2023: 7 · 2022: 2 · 2021: 13 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 5 · 2015: 6 · 2014: 12 · 2013: 4 · 2012: 3
FWCI
2.24
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Pharmaceutical Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (R01MH074672)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
in vitro-in vivo correlation, schizophrenia, antipsychotic drug delivery, single-screw extrusion, biodegradable polymer implants, drug release kinetics, bioavailability, locomotor activity, medication non-adherence, sustained drug release
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Humans, Male, Polyglycolic Acid, Schizophrenia, Antipsychotic Agents, Drug Delivery Systems, Rats, Sprague-Dawley, Risperidone, Lactic Acid, Absorbable Implants, Models, Animal, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. https://app.cochat.ai/papers/10.1007/s11095-010-0152-4
The paper
Amann, L. C., Gandal, M. J., Lin, R., Liang, Y., & Siegel, S. J. (2010). In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharmaceutical Research. https://doi.org/10.1007/s11095-010-0152-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.